Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6244133 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL3185955 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL27839473 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL139552 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL2168028 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL379535 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL10548181 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL3180143 | 1.00 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| Hydrochloric Acid SCHEMBL6224383 | 0.96 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL4506405 | 0.96 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115368244-A | Synthetic method of 2-aryl-2- (4-aminophenyl) propane | 北京鼎材科技有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115260151-A | Synthesis process of canagliflozin impurity | 上海予君生物科技发展有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-115028616-A | Canagliflozin impurity, preparation process and application thereof, and preparation process of compounds of formula II and formula III | 上海予君生物科技发展有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-114901712-A | AsPd (AcAc) of optical Material 2 UV active derivatives of L catalyzed polycycloolefin compositions | 普罗米鲁斯有限责任公司 | 2022-08-12 | — | — | CN | claimed |
| CN-108341739-B | Preparation method of alpha-aryl, heteroaryl or alkenyl-alpha, alpha-difluoromethyl compound | 中国科学院上海有机化学研究所 | 2022-07-19 | — | — | CN | claimed |
| CN-114502558-A | Method for preparing activin receptor-like kinase inhibitors | 缆图药品公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113788824-A | Pyridine compound | 第一三共株式会社 | 2021-12-14 | — | — | CN | claimed |
| CN-109661399-B | Cross-coupling method | 里科瑞尔姆IP控股有限责任公司 | 2021-09-07 | — | — | CN | claimed |
| CN-112055712-A | Processes and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections | 吉利德科学公司 | 2020-12-08 | — | — | CN | claimed |
| CN-110204558-A | The synthesis of cephalosporin compound | 默沙东公司 | 2019-09-06 | — | — | CN | claimed |
| CN-1329370-C | Process for the preparation of phenylmalonic acid dinitriles | SYNGENTA PARTICIPATIONS AG (CH) | 2007-08-01 | — | — | CN | claimed |
| EP-1776345-A2 | A MULTICORE INDAZOLINONE LIBRARY | The University Court of the University of St. Andrews (GB) | 2007-04-25 | — | — | EP | claimed |
| CN-1720221-A | Process for the preparation of phenylmalonic acid dinitriles | SYNGENTA PARTICIPATIONS AG (CH) | 2006-01-11 | — | — | CN | claimed |
| WO-2005121096-A2 | A MULTICORE INDAZOLINONE LIBRARY | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2005-12-22 | — | — | WO | claimed |
| US-6939985-B1 | covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2005-09-06 | — | — | US | claimed |
| US-20020193604-A1 | Aryl borates | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-12-19 | — | — | US | claimed |
| EP-0986541-A4 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMW SCIENT IND RES ORG (AU) | 2002-08-14 | — | — | EP | claimed |
| US-20020032339-A1 | ARYL BORATES | BORON MOLECULAR LIMITED (AU) | 2002-03-14 | — | — | US | claimed |
| EP-0986541-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-03-22 | — | — | EP | claimed |
| WO-1998045265-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-10-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193604-A1 | Aryl borates | BRD4, ABL1, BRD3 | ALDH1A1 1148/4885HSD17B10 1786/4885MGLL 3776/4885 |
| US-20020032339-A1 | ARYL BORATES | TBCB, HAT1, UBE2B | ALDH1A1 968/4885HSD17B10 1702/4885MGLL 4316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.